GlassScriptPhysician profile
Scott G Lilly
NPI 1841252145
$316.94
in general payments reported to CMS, 2019-2025
8 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.97 · 2023: $107 · 2024: $25.60 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $173.50 | 2023-2025 | Spravato |
| Otsuka America Pharmaceutical, INC. | $29.91 | 2023 | Rexulti |
| Irhythm Technologies, INC. | $25.60 | 2024 | Zio Monitor, Zio Xt Patch |
| Welch Allyn | $19.97 | 2021 | |
| Abbvie INC. | $19.90 | 2023 | |
| Alkermes, INC. | $18.82 | 2023 | Aristada, Lybalvi |
| Glaxosmithkline, LLC. | $14.88 | 2025 | Trelegy Ellipta |
| Axsome Therapeutics, INC. | $14.36 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Lilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.